Improving health
through
translational
genomics
WHAT IS GENOMICS
Genome is a word used to describe the genetic make-up of an individual. This includes our genes that are passed on from parent to offspring. Our genes contribute to many of our physical characteristics (i.e. eye colour and height). They can also impact our lifetime risk of developing certain medical conditions.
Genomics is a branch of science that studies the genome. Genomics looks at how our genes interact with each other, how they function and how they are structured. This study also compares how genomes are similar, and different, across animal species. Using a variety of scientific techniques all of this data is organized into databases which allows our scientists to further understand the genetic basis of disease.
Our Vision
Improving health through translational genomics.
Our Mission
To deliver medical genomic research that translates into life-changing tests and treatments for people affected by acquired and inherited diseases.
Our Partners
CGEM is an IWK Health Research Centre of Excellence. At its core, the mission of CGEM is to improve health outcomes for patients through genomics-based research and clinical application. Surrounding this central mission are five key areas of research expertise: Genetic Disease Diagnosis, Cancer Diagnosis & Treatments, Genetic Disease Drug Development & Trials, Medical Microbiome, and Ethics & Policy. These represent the core disciplines through which CGEM drives innovation and impact.
Supporting these areas of expertise is a network of partner institutions and facilities, each contributing specific capabilities. The IWK Health focuses on pediatric and family genetic diseases, cancer, microbiome, treatments and clinical trials. Nova Scotia Health (NSHA) plays a central role in adult cancer care, genetic disease management, and clinical trials. Dalhousie University supports the Genomics CORES Lab and contributes foundational research in drug discovery, genetics, microbiome, model organisms, and medical ethics. AGADA Biosciences supports orphan drug development, and CDRD Atlantic Node provides critical translational genetics and preclinical testing capacity. Together, these institutions form a collaborative ecosystem that empowers CGEM to translate genomics research into real-world medical solutions for patients.